Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Doris Leithner

Showing results (71-80 of 81) with videos related to

Pageof 9
Sort By:
European Radiology|January 6, 2026
Evaluating indeterminate bone lesions and lymph nodes on PSMA-PET: a multidisciplinary consensus algorithm and 1-year implementation resultsSungmin Woo, Angela Tong, Anton S Becker, et al.
Radiology. Artificial Intelligence|February 11, 2022
Radiologist-Level Performance by Using Deep Learning for Segmentation of Breast Cancers on MRI ScansLukas Hirsch, Yu Huang, Shaojun Luo, et al.
Bone Marrow Transplantation|February 1, 2025
Treatment failure patterns in early versus late introduction of CAR T-cell therapy in large B-cell lymphomaMagdalena Corona, Andrew Ip, Samantha Brown, et al.
Blood Cancer Journal|April 14, 2025
CAR T-cell therapy response varies by extranodal disease site in large B-cell lymphomaAlejandro Luna, Sean M Devlin, Kai Rejeski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 11, 2024
Metabolic Tumor Volume Response after Bridging Therapy Determines Chimeric Antigen Receptor T-Cell Outcomes in Large B-Cell LymphomaHarper Hubbeling, Doris Leithner, Emily A Silverman, et al.
Journal of Hematology & Oncology|April 22, 2024
Conventional and novel [<sup>18</sup>F]FDG PET/CT features as predictors of CAR-T cell therapy outcome in large B-cell lymphomaDoris Leithner, Jessica R Flynn, Sean M Devlin, et al.
Research Square|July 16, 2024
Calibrated CAR Signaling Enables Low-Dose Therapy in Large B-Cell LymphomaJae Park, M Lia Palomba, Karlo Perica, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 30, 2025
Results From First-in-Human Phase I Study of a Novel CD19-1XX Chimeric Antigen Receptor With Calibrated Signaling in Large B-Cell LymphomaJae H Park, M Lia Palomba, Karlo Perica, et al.
Blood Cancer Journal|August 26, 2025
Optimization and validation of the international metabolic prognostic index for CD19 CAR-T in large B-cell lymphomaMichael Winkelmann, Sandeep S Raj, Michael D Jain, et al.
Insights Into Imaging|March 26, 2024
How young radiologists use contrast media and manage adverse reactions: an international surveyDomenico Albano, Carmen Mallardi, Saif Afat, et al.
Pageof 9

Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
European Radiology|January 6, 2026
Evaluating indeterminate bone lesions and lymph nodes on PSMA-PET: a multidisciplinary consensus algorithm and 1-year implementation resultsSungmin Woo, Angela Tong, Anton S Becker, et al.
Radiology. Artificial Intelligence|February 11, 2022
Radiologist-Level Performance by Using Deep Learning for Segmentation of Breast Cancers on MRI ScansLukas Hirsch, Yu Huang, Shaojun Luo, et al.
Bone Marrow Transplantation|February 1, 2025
Treatment failure patterns in early versus late introduction of CAR T-cell therapy in large B-cell lymphomaMagdalena Corona, Andrew Ip, Samantha Brown, et al.
Blood Cancer Journal|April 14, 2025
CAR T-cell therapy response varies by extranodal disease site in large B-cell lymphomaAlejandro Luna, Sean M Devlin, Kai Rejeski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 11, 2024
Metabolic Tumor Volume Response after Bridging Therapy Determines Chimeric Antigen Receptor T-Cell Outcomes in Large B-Cell LymphomaHarper Hubbeling, Doris Leithner, Emily A Silverman, et al.
Journal of Hematology & Oncology|April 22, 2024
Conventional and novel [<sup>18</sup>F]FDG PET/CT features as predictors of CAR-T cell therapy outcome in large B-cell lymphomaDoris Leithner, Jessica R Flynn, Sean M Devlin, et al.
Research Square|July 16, 2024
Calibrated CAR Signaling Enables Low-Dose Therapy in Large B-Cell LymphomaJae Park, M Lia Palomba, Karlo Perica, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 30, 2025
Results From First-in-Human Phase I Study of a Novel CD19-1XX Chimeric Antigen Receptor With Calibrated Signaling in Large B-Cell LymphomaJae H Park, M Lia Palomba, Karlo Perica, et al.
Blood Cancer Journal|August 26, 2025
Optimization and validation of the international metabolic prognostic index for CD19 CAR-T in large B-cell lymphomaMichael Winkelmann, Sandeep S Raj, Michael D Jain, et al.
Insights Into Imaging|March 26, 2024
How young radiologists use contrast media and manage adverse reactions: an international surveyDomenico Albano, Carmen Mallardi, Saif Afat, et al.
Pageof 9